发明名称 USE OF UMBILICAL CORD BLOOD TO TREAT INDIVIDUALS HAVING A DISEASE, DISORDER OR CONDITION.
摘要 <p>The present invention provides methods of using cord blood and cord blood-derived stem cells in high doses to treat various conditions, diseases and disorders. The high-dose cord blood and cord blood-derived stem cells have a multitude of uses and applications including but not limited to, therapeutic uses for transplantation and treatment and prevention of disease, and diagnostic and research uses. In particular, the cord blood or cord blood-derived stem cells are delivered in high doses, e.g., at least 3 billion nucleated cells per treatment, where treatment may comprise a single or multiple infusions. The invention also provides for the use of cord blood or cord blood-derived stem cells from multiple donors without the need for HLA typing.</p>
申请公布号 MXPA05008445(A) 申请公布日期 2005.10.18
申请号 MX2005PA08445 申请日期 2004.02.13
申请人 ANTHROGENESIS CORPORATION 发明人 ROBERT J. HARIRI
分类号 A01N1/02;A01N63/00;A61B;A61K35/12;A61K35/14;A61K35/50;A61K45/00;C12N5/074 主分类号 A01N1/02
代理机构 代理人
主权项
地址